BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32594726)

  • 21. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
    Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fecal microbiota transplantation on antibiotic-associated diarrhea and its impact on gut microbiota.
    Wang L; Guo G; Xu Y; Li L; Yang B; Zhao D; Tian H; Ye C; Lin Z; Cui J; Li N; Huang L; Chen Q
    BMC Microbiol; 2024 May; 24(1):160. PubMed ID: 38724904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
    Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL
    PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term outcomes of 328 patients with of autism spectrum disorder after fecal microbiota transplantation].
    Ye C; Chen QY; Ma XQ; Lv P; Yang HL; Tian D; Zhao ZL; Lin JQ; Cui N; Li HL; Qin H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Sep; 25(9):798-803. PubMed ID: 36117371
    [No Abstract]   [Full Text] [Related]  

  • 26. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
    Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
    Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
    Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
    Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
    Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than
    Green JE; Davis JA; Berk M; Hair C; Loughman A; Castle D; Athan E; Nierenberg AA; Cryan JF; Jacka F; Marx W
    Gut Microbes; 2020 Nov; 12(1):1-25. PubMed ID: 33345703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.
    Rossen NG; MacDonald JK; de Vries EM; D'Haens GR; de Vos WM; Zoetendal EG; Ponsioen CY
    World J Gastroenterol; 2015 May; 21(17):5359-71. PubMed ID: 25954111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry.
    Yau YK; Lau LHS; Lui RNS; Wong SH; Guo CL; Mak JWY; Ching JYL; Ip M; Kamm MA; Rubin DT; Chan PKS; Chan FKL; Ng SC
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):611-620.e12. PubMed ID: 37734581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
    Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
    Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.